While the buyers are passive managers (suggesting index-driven flows rather than active conviction), the scale of new positions — especially Schwab’s $972K entry and Morgan Stanley’s 6x increase — signals growing institutional footprint. Traders should monitor for follow-through buying and potential float concentration, particularly if active managers begin to participate.
Executive Summary
Three major passive institutions — Morgan Stanley, Wells Fargo, and Schwab — significantly increased their positions in Zenas BioPharma during Q4 2024, collectively adding $3.1M in new holdings with no institutional selling observed. This cluster reflects strong institutional accumulation, driven entirely by large passive managers entering or doubling down on positions.
Key Financial Metrics
Institutional Positions
Net institutional flow: $3.1M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +601.7% | $2.9M | $2.1M |
| Wells Fargo | NEW | +0% | $65.0K | $65.0K |
| Schwab | NEW | +0% | $972.0K | $972.0K |
Key Facts
- Morgan Stanley doubled its position, increasing shares from 51.0K to 358.2K (Δ+307.2K) and value from $864K to $2.9M (Δ+$2.1M)
- Wells Fargo initiated a new position of 8.0K shares worth $65K
- Schwab initiated a new position of 118.7K shares worth $972K
- No institutional sellers were identified in this quarter
Financial Impact
3 institutions accumulated $3.1M in net new positions during Q4 2024 with no offsetting sales
Risk Factors
- All buyers are mega-passive institutions, indicating the move may reflect index inclusion or rebalancing rather than fundamental conviction
- No active or activist funds are participating, limiting the strength of the signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ZBIO-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Press Release | $26.71 | awaiting T+60 | — | — |
Oct 13, 2026 14d ago | 8-K | $25.16 | awaiting T+60 | — | — |
Sep 22, 2026 5w ago | Press Release | $33.05 | awaiting T+60 | — | — |
Sep 18, 2026 5w ago | Press Release | $32.55 | awaiting T+60 | — | — |
Sep 11, 2026 6w ago | S-3ASR | $31.91 | awaiting T+60 | — | — |
May 28, 2026 21w ago | Press Release | $18.56 $32.29 | ▲ +73.98% | ▲ +72.24% | — |
May 19, 2026 23w ago | Press Release | $17.84 $29.20 | ▲ +63.68% | ▲ +57.39% | — |
May 13, 2026 23w ago | Press Release | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | — |
May 13, 2026 23w ago | 8-K | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | — |
May 13, 2026 23w ago | Press Release | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers